Getting Started on PULMICORT RESPULES

PULMICORT RESPULES® Asthma Medication

Is it time for your child to start using an asthma maintenance medication? For children with asthma using a rescue inhaler more than two or three times a week, it may be a good idea to talk to a doctor about adding PULMICORT RESPULES, an FDA-approved asthma maintenance medication created just for kids to control and prevent asthma symptoms. Although using an asthma medication every day may seem a little overwhelming, PULMICORT RESPULES provides the following:

  • Helps reduce swelling and inflammation in the lungs, and helps keep the airways open to reduce asthma symptoms
  • By breathing through a jet nebulizer, your child receives the medicine in his or her lungs
  • Available in a once-daily dosing option or, if not adequately effective, as a twice-daily dosing option

It’s important to remember that, because they aren’t intended to provide fast relief, asthma controller medications should not be used to treat sudden symptoms.


Get tips from other moms on how to make jet nebulizing easier for your child when you download the Mom’s Guide to Jet Nebulizing .

Facts about PULMICORT RESPULES

PULMICORT RESPULES is

  • A maintenance medicine used to reduce inflammation in the lungs and help control and prevent asthma symptoms, which can lead to an attack
  • Shown in studies to decrease daytime and nighttime asthma symptoms in children
Next:



Some files on this page require Adobe® Reader® to be installed. If you do not have Adobe Reader on your computer, you can download it here.
 

Doctor Discussion Guide

 

Learn how to talk to your doctor and help improve your child's asthma symptoms with the Doctor Discussion Guide.


Side Effects

 

It's important to educate yourself and talk to your doctor about the safety information for PULMICORT RESPULES.

 
1171404-3175607 Last updated 9/15

IMPORTANT INFORMATION ABOUT PULMICORT RESPULES

Important Safety Information

PULMICORT RESPULES is not a bronchodilator and should NOT be used to treat an acute asthma attack. If your child is switching to PULMICORT RESPULES from an oral corticosteroid, follow the doctor's instructions to avoid serious health risks when your child stops using oral corticosteroids.

Only use PULMICORT RESPULES with a jet nebulizer machine that is connected to an air compressor. Do not use an ultrasonic nebulizer.

Thrush infection of the mouth and throat may occur with PULMICORT RESPULES.

Avoid exposure of your child to infections such as chicken pox and measles. Tell your doctor immediately if your child is exposed.

Inhaled corticosteroids may cause a reduction in growth rate. The long-term effect on final adult height is unknown.

PULMICORT RESPULES should not be used if your child is allergic to budesonide or any of the ingredients.

Be sure to tell the healthcare provider about all your child's health conditions and all medicines he or she may be taking.

As with other inhaled asthma medications, bronchospasm, with an immediate increase in wheezing, may occur after dosing. If bronchospasm occurs following dosing with PULMICORT RESPULES, it should be treated immediately with a fast-acting inhaled bronchodilator. Treatment with PULMICORT RESPULES should be stopped and your physician consulted.

The most common side effects include respiratory infection, runny nose, coughing, ear infection, viral infection, thrush in the mouth and throat, inflammation of the stomach including vomiting, diarrhea, abdominal pain and loss of appetite, nose bleed, pink eye, and rash.

Approved Use

PULMICORT RESPULES® (budesonide inhalation suspension) is a maintenance medicine used to control and prevent asthma symptoms in children ages 12 months to 8 years.

Please click here for full Prescribing Information for PULMICORT RESPULES.

You are encouraged to report negative side effects of prescription drugs to the FDA.

Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

This product information is intended for US consumers only.

PULMICORT RESPULES is a registered trademark of the AstraZeneca group of companies.

PARI JET PLUS Nebulizer and PARI MASTER Compressor are registered trademarks of PARI Respiratory Equipment, Inc.

©2016 AstraZeneca. All rights reserved. 1171404-3175607 Last Updated 3/16